203 related articles for article (PubMed ID: 30031714)
1. Holistic psychosocial determinants of adherence to medication in people with type 2 diabetes.
Reach G; Pellan M; Crine A; Touboul C; Ciocca A; Djoudi Y
Diabetes Metab; 2018 Dec; 44(6):500-507. PubMed ID: 30031714
[TBL] [Abstract][Full Text] [Related]
2. Using the extended self-regulatory model to characterise diabetes medication adherence: a cross-sectional study.
Shiyanbola OO; Unni E; Huang YM; Lanier C
BMJ Open; 2018 Nov; 8(11):e022803. PubMed ID: 30478112
[TBL] [Abstract][Full Text] [Related]
3. Medication adherence in type 2 diabetes patients in Nigeria.
Jackson IL; Adibe MO; Okonta MJ; Ukwe CV
Diabetes Technol Ther; 2015 Jun; 17(6):398-404. PubMed ID: 25749392
[TBL] [Abstract][Full Text] [Related]
4. Psychosocial factors associated with adherence to non-insulin antidiabetes treatments.
Guénette L; Breton MC; Guillaumie L; Lauzier S; Grégoire JP; Moisan J
J Diabetes Complications; 2016 Mar; 30(2):335-42. PubMed ID: 26615905
[TBL] [Abstract][Full Text] [Related]
5. Patient factors associated with diabetes medication adherence at different health literacy levels: a cross-sectional study at a family medicine clinic.
Huang YM; Shiyanbola OO; Chan HY; Smith PD
Postgrad Med; 2020 May; 132(4):328-336. PubMed ID: 32233892
[TBL] [Abstract][Full Text] [Related]
6. Adherence to antidiabetic medication and factors associated with non-adherence among patients with type-2 diabetes mellitus in two regional hospitals in Cameroon.
Aminde LN; Tindong M; Ngwasiri CA; Aminde JA; Njim T; Fondong AA; Takah NF
BMC Endocr Disord; 2019 Apr; 19(1):35. PubMed ID: 30943969
[TBL] [Abstract][Full Text] [Related]
7. Diabetes distress and peripheral neuropathy are associated with medication non-adherence in individuals with type 2 diabetes in primary care.
Zhang ZP; Premikha M; Luo M; Venkataraman K
Acta Diabetol; 2021 Mar; 58(3):309-317. PubMed ID: 33211180
[TBL] [Abstract][Full Text] [Related]
8. Determinants of adherence to diabetes treatment.
Larkin AT; Hoffman C; Stevens A; Douglas A; Bloomgarden Z
J Diabetes; 2015 Nov; 7(6):864-71. PubMed ID: 25565088
[TBL] [Abstract][Full Text] [Related]
9. Psychosocial determinants of adherence to oral antidiabetic medication among people with type 2 diabetes.
Jannuzzi FF; Cornélio ME; São-João TM; Gallani MC; Godin G; Rodrigues RCM
J Clin Nurs; 2020 Mar; 29(5-6):909-921. PubMed ID: 31856319
[TBL] [Abstract][Full Text] [Related]
10. Factors associated with antidiabetic medication non-adherence in patients with incident comorbid depression.
Lunghi C; Zongo A; Moisan J; Grégoire JP; Guénette L
J Diabetes Complications; 2017 Jul; 31(7):1200-1206. PubMed ID: 28325698
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of antidiabetic medication adherence in the Lebanese population: development of the Lebanese Diabetes Medication Adherence Scale.
Ayoub D; Mroueh L; El-Hajj M; Awada S; Rachidi S; Zein S; Al-Hajje A
Int J Pharm Pract; 2019 Oct; 27(5):468-476. PubMed ID: 31264750
[TBL] [Abstract][Full Text] [Related]
12. Patients' impatience is an independent determinant of poor diabetes control.
Reach G; Michault A; Bihan H; Paulino C; Cohen R; Le Clésiau H
Diabetes Metab; 2011 Dec; 37(6):497-504. PubMed ID: 21550831
[TBL] [Abstract][Full Text] [Related]
13. Patient and physician factors associated with adherence to diabetes medications.
Schoenthaler AM; Schwartz BS; Wood C; Stewart WF
Diabetes Educ; 2012; 38(3):397-408. PubMed ID: 22446035
[TBL] [Abstract][Full Text] [Related]
14. Medication beliefs, treatment complexity, and non-adherence to different drug classes in patients with type 2 diabetes.
de Vries ST; Keers JC; Visser R; de Zeeuw D; Haaijer-Ruskamp FM; Voorham J; Denig P
J Psychosom Res; 2014 Feb; 76(2):134-8. PubMed ID: 24439689
[TBL] [Abstract][Full Text] [Related]
15. Venue of receiving diabetes self-management education and training and its impact on oral diabetic medication adherence.
Wu J; Davis-Ajami ML; Noxon V; Lu ZK
Prim Care Diabetes; 2017 Apr; 11(2):162-170. PubMed ID: 27840086
[TBL] [Abstract][Full Text] [Related]
16. Physician experiences when discussing the need for additional oral medication with type 2 diabetes patients: Insights from the cross-national IntroDia® study.
Down S; Alzaid A; Polonsky WH; Belton A; Edelman S; Gamerman V; Nagel F; Lee J; Emmerson J; Capehorn M
Diabetes Res Clin Pract; 2019 Feb; 148():179-188. PubMed ID: 30641173
[TBL] [Abstract][Full Text] [Related]
17. Patient Characteristics Associated With Medication Adherence to Anti-Diabetic Drugs.
Shaha KC; Sultana S; Saha SK; Shahidullah SM; Jyoti BK
Mymensingh Med J; 2019 Apr; 28(2):423-428. PubMed ID: 31086161
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of illness perceptions and their associations with glycaemic control, medication adherence and chronic kidney disease in type 2 diabetes mellitus patients in Malaysia.
Balasubramaniam S; Lim SL; Goh LH; Subramaniam S; Tangiisuran B
Diabetes Metab Syndr; 2019; 13(4):2585-2591. PubMed ID: 31405680
[TBL] [Abstract][Full Text] [Related]
19. Associations between antidepressant adherence and shared decision-making, patient-provider trust, and communication among adults with diabetes: diabetes study of Northern California (DISTANCE).
Bauer AM; Parker MM; Schillinger D; Katon W; Adler N; Adams AS; Moffet HH; Karter AJ
J Gen Intern Med; 2014 Aug; 29(8):1139-47. PubMed ID: 24706097
[TBL] [Abstract][Full Text] [Related]
20. [Factors associated with medication non-adherence in patients with type 2 diabetes mellitus: The first Algerian survey].
Achouri MY; Mammeri M; Sehanine Y; Selka MA; Ghomari WI; Lahmer A; Hadj Habib M
Ann Pharm Fr; 2019 Nov; 77(6):506-515. PubMed ID: 31564421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
